Skip to main content
Livermore
Livermore
ZHEN

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

CORT holding history

Corcept Therapeutics Inc in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CORT overviewAll 13F holders of CORTFull Q2 2026 holdings

Shares (Q2 2026)
7,934,507
Value
$689.9M
% of portfolio
18.8%
Quarters held
22
Since Q1 2021
Holdings of CORT by Ingalls & Snyder LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,934,507$689.9M18.8%+325,791+4.3%AddedHolders
Q1 20267,608,716$306.7M10.9%+413,656+5.7%AddedHolders
Q4 20257,195,060$250.4M9.2%−502,924−6.5%ReducedHolders
Q3 20257,697,984$639.8M21.0%−24,938−0.3%ReducedHolders
Q2 20257,722,922$566.9M20.2%−19,662−0.3%ReducedHolders
Q1 20257,742,584$884.4M29.2%−357,163−4.4%ReducedHolders
Q4 20248,099,747$408.1M16.1%−167,009−2.0%ReducedHolders
Q3 20248,266,756$382.6M15.0%+28,650+0.3%AddedHolders
Q2 20248,238,106$267.7M11.6%−65,041−0.8%ReducedHolders
Q1 20248,303,147$209.2M9.3%−48,680−0.6%ReducedHolders
Q4 20238,351,827$271.3M12.3%+11,634+0.1%AddedHolders
Q3 20238,340,193$227.2M11.0%−20,292−0.2%ReducedHolders
Q2 20238,360,485$186.0M9.0%−9,532−0.1%ReducedHolders
Q1 20238,370,017$181.3M9.4%+1,544,755+22.6%AddedHolders
Q4 20226,825,262$138.6M7.6%−125,815−1.8%ReducedHolders
Q3 20226,951,077$178.2M10.0%−41,171−0.6%ReducedHolders
Q2 20226,992,248$166.3M8.8%+80,872+1.2%AddedHolders
Q1 20226,911,376$155.6M7.0%+173,478+2.6%AddedHolders
Q4 20216,737,898$133.4M6.1%−315,472−4.5%ReducedHolders
Q3 20217,053,370$138.8M6.4%−17,785−0.3%ReducedHolders
Q2 20217,071,155$155.6M7.0%+124,423+1.8%AddedHolders
Q1 20216,946,732$165.3M7.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.